2017-02-11 · Immunicum Announces Investor Event and Conference Participation for April. Press Release 7 April 2021 Immunicum Announces Investor Event and Conference Participation for April Immunicum AB (publ

Immunicum AB (publ: IMMU.ST) today announced preclinical data supporting the combination of ilixadencel, an off-the-shelf, cell-based immune primer, with cancer therapies and immunotherapies including anti-VEGF, anti-PD1 and anti-CTLA4 during a poster presentation at the 2020 Virtual ESMO Congress.

Trophic Communications Telephone: +49 171 351 2733 E-mail: ir@immunicum.com. ABOUT IMMUNICUM AB (PUBL) 16 Dec 2020 Immunicum AB (publ) Publishes Financial Calendar 2021 Investor Relations. Jonas Rodny and Carolin Wiken E-mail: ir@immunicum.com. 5 dagar sedan E-mail: ir@immunicum.com. investerarrelationer. Sijme Zeilemaker Head of Investor Relations & Corporate Communication Telephone: +46 8 16 Dec 2020 Immunicum AB (publ) Publishes Financial Calendar 2021 Investor Relations. Jonas Rodny and Carolin Wiken E-mail: ir@immunicum.com.

INVESTOR RELATIONS och Mediakontakt EU/US Gretchen Schweitzer Trophic Communications Telefon: +49 172 861 8540 E-post: ir@immunicum.com. Bolagets Certified Adviser är Redeye AB 2021-04-14 · E-mail: ir@immunicum.com. Investor Relations. Sijme Zeilemaker Head of Investor Relations & Corporate Communication Telephone: +46 8 732 8400 E-mail: ir@immunicum.com. Media Relations. Eva Mulder and Sophia Hergenhan Trophic Communications Telephone: +49 175 222 57 56 E-mail: immu@trophic.eu.

Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual Investor Event on Wednesday, December 9 th at 15:00 CET. During the Investor Event, Immunicum will provide an overview of the proposed Transaction with DCprime and will lead a Q&A session. 2021-04-12 · Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Company’s corporate website: www.immunicum.com. Immunicum shareholders can request a printed Immunicum AB: Invitation to Investor Event Immunicum AB (publ; IMMU.ST) announced today that the Company will host an investor event in Kalmar on June 13 starting at 18:00 CEST.

Press Release 1 December 2020 Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9th Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual Investor Event on Wednesday, December 9th at 15:00 CET. During the Investor Event, Immunicum will provide an overview of the proposed Transaction with DCprime and will lead a Q&A session.

Trophic Communications Telefon: +49 171 351 2733. E-post: ir@immunicum.com. Om Immunicum AB (publ. Aktieägarna i Immunicum AB (publ) (”Bolaget”), org.nr 556629-1786, Sijme Zeilemaker, M.Sc., Head of Investor Relations and Corporate Telephone: +49 171 351 2733.

Wealth Shortlist fund · About us · Investor relations · Corporate Social Responsibility · Press · Careers · Affiliate program · Sitemap · Share this page.

Immunicum AB (publ) Publishes the Annual Report for 2020.

Jonas Rodny and Carolin Wiken Paues Åberg Communications Telephone: +46 190 90 51 E-mail: ir@immunicum.com.
Spiritualism vs materialism

Om Secits. Secits är ett spjutspetsföretag inom kamera- och sensorövervakning. Secits Holding AB Bokslutskommuniké 2020 Investor Relations Gaming Corps AB is a public limited company listed on Nasdaq First North Growth Market under the ticker GCOR with ISIN code SE0014694691. Gaming Corps AB began trading on Nasdaq First North Growth Market on June 4, 2015. 2021-04-12 · Press Release 12 April 2021 Immunicum AB (publ) Publishes the Annual Report for 2020 Immunicum AB (publ; IMMU.ST), today announced that its Annua 2017-11-22 · Press release.

Investor relations. Acrinova AB är noterat på Nasdaq First North Premier Growth Market. Här hittar du Acrinovas aktieinformation, bolagsstyrning, kalendarium, pressmeddelanden och finansiella rapporter. Vi på Acrinova, som börsnoterat företag arbetar aktivt för att informationsgivningen ska vara öppen och tydlig.
Pajala blocket.se

schoolsoft runby skola
julmust från norrland
eksklusiv moms betyder
apotea börsnoterat
bygghuset roslagstull

Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9 th. Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual Investor Event on Wednesday, December 9 th at 15:00 CET. During the Investor Event, Immunicum will provide an overview of the proposed Transaction with DCprime and will lead a Q&A session.

Media Relations E-mail: info@immunicum.com. INVESTOR RELATIONS . Jonas Rodny and Carolin Wiken Paues Åberg Communications Telephone: +46 190 90 51 E-mail: ir@immunicum.com.

HomeMaid AB, Investor Relations, IR, rapporter, finansiell information, största aktieägare, bolagsstämma

Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel immune-priming cancer treatment against a variety of solid tumors, today announced that CEO Carlos de Sousa will present the Company as well as provide background on the previously announced proposed Rights Issue at two upcoming investor events. 2016-03-14 · Julie Silber, Investor Relations ir@immunicum.com Telephone: +46 (0)7 93 486 277, Europe Telephone: +1 310 766 9760, North America. About Immunicum AB (publ) Immunicum AB (publ) Efter registrering kommer bolaget ha 10 677 168 aktier samt 1 067 716,8 sek i aktiekapital. I samband med teckning av aktier har New Equity Venture ingått avtal om lock up av samtliga innehavda aktier i Game Chest group AB per 2020-06-16 till och med 2020-08-31. // Investor Relations Game Chest Group AB(publ) ir@gamechestgroup.se Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9 th. Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual Investor Event on Wednesday, December 9 th at 15:00 CET. During the Investor Event, Immunicum will provide an overview of the proposed Transaction with DCprime and will lead a Q&A session. 2021-04-12 · Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Company’s corporate website: www.immunicum.com.

Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9 th. Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual 2021-02-01 Press Release 23 November 2020 Immunicum AB (publ) Announces Upcoming Investor Conferences in November and December Immunicum AB (publ; IMMU.ST) announced today that members of the management team will be presenting at upcoming conferences in November and December.